Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

GABArho receptor antagonists described by University of California

June 17, 1997

Botulinum toxin type A evaluated in cerebral palsy

June 16, 1997

Friedreich's ataxia: possible cause and potential treatments

June 16, 1997

Boston Life Sciences receives notice of patent allowance for CNS growth factor

June 16, 1997

BMS-180048 vs. placebo for acute treatment of migraine

June 16, 1997

Melatonin evaluated in emergency physicians on the night shift

June 13, 1997

Gensia receives FDA approval of ANDA for atracurium besilate

June 13, 1997

Carvedilol and its metabolite attenuate Hb-mediated neuronal injury

June 13, 1997

Chiral TNF inhibitors reported by Schering AG

June 11, 1997

Physostigmine improves working memory and alters neural activity in volunteers

June 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...